Culturing Primary Human Mesothelial Cells.


Journal

Methods in molecular biology (Clifton, N.J.)
ISSN: 1940-6029
Titre abrégé: Methods Mol Biol
Pays: United States
ID NLM: 9214969

Informations de publication

Date de publication:
2022
Historique:
entrez: 17 12 2021
pubmed: 18 12 2021
medline: 28 1 2022
Statut: ppublish

Résumé

Mesothelial cells line the serosal cavities and associated organs. In order to metastasize to distant organs, ovarian tumor cells must first attach and then clear the mesothelial cells. Therefore, human primary mesothelial cells (HPMCs) are necessary to effectively study ovarian cancer metastases. Here, we describe methods to obtain HPMCs from human omentum and to culture in vitro.

Identifiants

pubmed: 34918292
doi: 10.1007/978-1-0716-1956-8_9
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

147-154

Informations de copyright

© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Références

Mutsaers SE (2004) The mesothelial cell. Int J Biochem Cell Biol 36(1):9–16. https://doi.org/10.1016/S1357-2725(03)00242-5
doi: 10.1016/S1357-2725(03)00242-5 pubmed: 14592528
Mutsaers SE (2002) Mesothelial cells: their structure, function and role in serosal repair. Respirology 7(3):171–191. https://doi.org/10.1046/j.1440-1843.2002.00404.x
doi: 10.1046/j.1440-1843.2002.00404.x pubmed: 12153683
Ferrandez-Izquierdo A, Navarro-Fos S, Gonzalez-Devesa M, Gil-Benso R, Llombart-Bosch A (1994) Immunocytochemical typification of mesothelial cells in effusions: in vivo and in vitro models. Diagn Cytopathol 10(3):256–262. https://doi.org/10.1002/dc.2840100313
doi: 10.1002/dc.2840100313 pubmed: 7519540
Foley-Comer AJ, Herrick SE, Al-Mishlab T, Prêle CM, Laurent GJ, Mutsaers SE (2002) Evidence for incorporation of free-floating mesothelial cells as a mechanism of serosal healing. J Cell Sci 115(Pt 7):1383–1389
doi: 10.1242/jcs.115.7.1383 pubmed: 11896186
Jones LM, Gardner MJ, Catterall JB, Turner GA (1995) Hyaluronic acid secreted by mesothelial cells: a natural barrier to ovarian cancer cell adhesion. Clin Exp Metastasis 13(5):373–380. https://doi.org/10.1007/bf00121913
doi: 10.1007/bf00121913 pubmed: 7641421
Cunliffe WJ, Sugarbaker PH (1989) Gastrointestinal malignancy: rationale for adjuvant therapy using early postoperative intraperitoneal chemotherapy. Br J Surg 76(10):1082–1090. https://doi.org/10.1002/bjs.1800761030
doi: 10.1002/bjs.1800761030 pubmed: 2688796
Lengyel E (2010) Ovarian cancer development and metastasis. Am J Pathol 177(3):1053–1064. https://doi.org/10.2353/ajpath.2010.100105
doi: 10.2353/ajpath.2010.100105 pubmed: 20651229 pmcid: 2928939
Rieppi M, Vergani V, Gatto C, Zanetta G, Allavena P, Taraboletti G, Giavazzi R (1999) Mesothelial cells induce the motility of human ovarian carcinoma cells. Int J Cancer 80(2):303–307. https://doi.org/10.1002/(sici)1097-0215(19990118)80:2<303::aid-ijc21>3.0.co;2-w
doi: 10.1002/(sici)1097-0215(19990118)80:2<303::aid-ijc21>3.0.co;2-w pubmed: 9935214
Kenny HA, Chiang CY, White EA, Schryver EM, Habis M, Romero IL, Ladanyi A, Penicka CV, George J, Matlin K, Montag A, Wroblewski K, Yamada SD, Mazar AP, Bowtell D, Lengyel E (2014) Mesothelial cells promote early ovarian cancer metastasis through fibronectin secretion. J Clin Invest 124(10):4614–4628. https://doi.org/10.1172/jci74778
doi: 10.1172/jci74778 pubmed: 25202979 pmcid: 4191043

Auteurs

Mary Mullen (M)

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, USA.

Hollie Noia (H)

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, USA.

Katherine Fuh (K)

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Washington University School of Medicine and Alvin J. Siteman Cancer Center, St. Louis, MO, USA. kfuh@wustl.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH